BioCentury
ARTICLE | Company News

Carrington, National Institutes of Health deal

May 26, 2008 7:00 AM UTC

Carrington’s DelSite Biotechnologies Inc. subsidiary extended a license to evaluate NIH’s polysaccharide technology’s ability to create a typhoid vaccine with DelSite’s GelSite delivery polymer. Terms...